Group One Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11M | Sell |
26,400
-38,200
| -59% | -$3.15M | ﹤0.01% | 2023 |
|
|
2025
Q4 | $5.51M | Buy |
64,600
+38,800
| +150% | +$3.18M | 0.01% | 1400 |
|
|
2025
Q3 | $2.01M | Sell |
25,800
-2,300
| -8% | -$180K | ﹤0.01% | 2317 |
|
|
2025
Q2 | $2.2M | Sell |
28,100
-73,800
| -72% | -$5.5M | ﹤0.01% | 2050 |
|
|
2025
Q1 | $7.39M | Buy |
101,900
+14,200
| +16% | +$1.02M | 0.02% | 793 |
|
|
2024
Q4 | $6.49M | Sell |
87,700
-149,600
| -63% | -$10.5M | 0.01% | 973 |
|
|
2024
Q3 | $15.7M | Buy |
237,300
+224,400
| +1,740% | +$16.3M | 0.04% | 380 |
|
|
2024
Q2 | $1.19M | Buy |
12,900
+300
| +2% | +$26.6K | ﹤0.01% | 1852 |
|
|
2024
Q1 | $1.2M | Sell |
12,600
-6,100
| -33% | -$512K | ﹤0.01% | 1919 |
|
|
2023
Q4 | $1.43M | Buy |
18,700
+6,100
| +48% | +$424K | ﹤0.01% | 2140 |
|
|
2023
Q3 | $873K | Sell |
12,600
-23,400
| -65% | -$1.88M | ﹤0.01% | 2406 |
|
|
2023
Q2 | $3.4M | Buy |
36,000
+1,400
| +4% | +$122K | 0.01% | 1266 |
|
|
2023
Q1 | $2.86M | Sell |
34,600
-57,900
| -63% | -$4.55M | 0.01% | 1236 |
|
|
2022
Q4 | $6.9M | Buy |
92,500
+11,000
| +13% | +$848K | 0.02% | 953 |
|
|
2022
Q3 | $6.73M | Buy |
81,500
+3,900
| +5% | +$375K | 0.01% | 957 |
|
|
2022
Q2 | $7.38M | Sell |
77,600
-22,600
| -23% | -$2.34M | 0.01% | 1048 |
|
|
2022
Q1 | $11.8M | Buy |
100,200
+8,900
| +10% | +$998K | 0.01% | 882 |
|
|
2021
Q4 | $11.8M | Buy |
91,300
+29,300
| +47% | +$3.42M | 0.01% | 994 |
|
|
2021
Q3 | $7.02M | Buy |
62,000
+10,300
| +20% | +$1.18M | 0.01% | 1382 |
|
|
2021
Q2 | $5.36M | Buy |
51,700
+22,100
| +75% | +$2.08M | 0.01% | 1623 |
|
|
2021
Q1 | $2.48M | Sell |
29,600
-31,900
| -52% | -$2.7M | ﹤0.01% | 2230 |
|
|
2020
Q4 | $5.61M | Sell |
61,500
-7,300
| -11% | -$606K | 0.01% | 1190 |
|
|
2020
Q3 | $5.49M | Buy |
68,800
+57,600
| +514% | +$4.49M | 0.02% | 861 |
|
|
2020
Q2 | $774K | Sell |
11,200
-111,500
| -91% | -$7.92M | ﹤0.01% | 2268 |
|
|
2020
Q1 | $7.71M | Buy |
122,700
+102,000
| +493% | +$7.36M | 0.06% | 340 |
|
|
2019
Q4 | $1.61M | Buy |
20,700
+12,000
| +138% | +$937K | 0.01% | 1469 |
|
|
2019
Q3 | $638K | Sell |
8,700
-61,800
| -88% | -$4.34M | 0.01% | 2127 |
|
|
2019
Q2 | $4.34M | Sell |
70,500
-127,500
| -64% | -$7.71M | 0.04% | 605 |
|
|
2019
Q1 | $12.6M | Buy |
198,000
+143,100
| +261% | +$8.17M | 0.14% | 136 |
|
|
2018
Q4 | $2.8M | Sell |
54,900
-144,000
| -72% | -$7.29M | 0.02% | 807 |
|
|
2018
Q3 | $11.5M | Buy |
198,900
+39,600
| +25% | +$1.94M | 0.09% | 246 |
|
|
2018
Q2 | $7.73M | Buy |
159,300
+109,500
| +220% | +$5.11M | 0.07% | 350 |
|
|
2018
Q1 | $2.32M | Sell |
49,800
-4,200
| -8% | -$182K | 0.02% | 913 |
|
|
2017
Q4 | $2.03M | Buy |
54,000
+300
| +0.6% | +$11K | 0.01% | 1176 |
|
|
2017
Q3 | $1.96M | Buy |
53,700
+27,600
| +106% | +$1.05M | 0.02% | 1066 |
|
|
2017
Q2 | $1.03M | Buy |
26,100
+13,500
| +107% | +$493K | 0.01% | 1431 |
|
|
2017
Q1 | $395K | Sell |
12,600
-105,600
| -89% | -$3.31M | ﹤0.01% | 2011 |
|
|
2016
Q4 | $3.69M | Buy |
118,200
+90,000
| +319% | +$2.92M | 0.04% | 561 |
|
|
2016
Q3 | $1.13M | Buy |
28,200
+16,200
| +135% | +$610K | 0.01% | 1191 |
|
|
2016
Q2 | $399K | Sell |
12,000
-31,200
| -72% | -$1.07M | ﹤0.01% | 1897 |
|
|
2016
Q1 | $1.27M | Buy |
43,200
+12,600
| +41% | +$348K | 0.02% | 1018 |
|
|
2015
Q4 | $806K | Buy |
30,600
+600
| +2% | +$15.6K | 0.01% | 1464 |
|
|
2015
Q3 | $711K | Buy |
30,000
+3,000
| +11% | +$72.4K | 0.01% | 1508 |
|
|
2015
Q2 | $641K | Sell |
27,000
-72,000
| -73% | -$1.62M | 0.01% | 1571 |
|
|
2015
Q1 | $2.35M | Sell |
99,000
-41,400
| -29% | -$929K | 0.04% | 560 |
|
|
2014
Q4 | $2.98M | Buy |
140,400
+34,800
| +33% | +$699K | 0.05% | 456 |
|
|
2014
Q3 | $1.8M | Sell |
105,600
-19,800
| -16% | -$313K | 0.03% | 749 |
|
|
2014
Q2 | $1.79M | Buy |
125,400
+81,000
| +182% | +$1.1M | 0.03% | 773 |
|
|
2014
Q1 | $549K | Sell |
44,400
-58,800
| -57% | -$678K | 0.01% | 1570 |
|
|
2013
Q4 | $1.13M | Sell |
103,200
-97,800
| -49% | -$1.1M | 0.02% | 1019 |
|
|
2013
Q3 | $2.33M | Buy |
201,000
+167,400
| +498% | +$1.96M | 0.04% | 476 |
|
|
2013
Q2 | $376K | Buy |
+33,600
| New | +$398K | 0.01% | 1583 |
|
Other funds holding EW
VCM
VPM
Group One Trading's EW Position: Q1 2026 in Review
Group One Trading opened a new position in Edwards Lifesciences (EW) in Q1 2026: 4,418 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #3655 among its holdings. This is a return to the name: Group One Trading previously reported a position in EW as recently as Q2 2025.
Group One Trading first reported a position in EW in Q2 2013 and has held it in 28 quarters since. The position peaked at $3.98M in Q4 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Group One Trading held 4,418 shares of Edwards Lifesciences worth $354K as of Q1 2026.
- Edwards Lifesciences was a new Group One Trading position in Q1 2026.
- Edwards Lifesciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3655 holding.
- Group One Trading first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 28 quarters since.
- Group One Trading's Edwards Lifesciences position peaked at $3.98M in Q4 2024.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.